Black Rock Inc. Fennec Pharmaceuticals Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,187,242 shares of FENC stock, worth $6.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,187,242

Previous 927,466 28.01%

Holding current value

$6.17 Million

Previous $10.3 Million 29.66%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.02 - $10.99 $1.56 Million - $2.85 Million	259,776 Added 28.01%	1,187,242 $7.25 Million
Q1 2024 May 10, 2024	SELL	$8.82 - $11.12 $62,842 - $79,230	-7,125 Reduced 0.76%	927,466 $10.3 Million
Q4 2023 Feb 13, 2024	BUY	$6.48 - $11.61 $580,284 - $1.04 Million	89,550 Added 10.6%	934,591 $10.5 Million
Q3 2023 Nov 13, 2023	BUY	$7.15 - $8.94 $106,692 - $133,402	14,922 Added 1.8%	845,041 $6.35 Million
Q2 2023 Aug 11, 2023	BUY	$7.27 - $9.82 $5.66 Million - $7.64 Million	778,481 Added 1507.57%	830,119 $7.33 Million
Q1 2023 May 12, 2023	BUY	$7.38 - $10.35 $8,073 - $11,322	1,094 Added 2.16%	51,638 $429,000
Q4 2022 Feb 13, 2023	BUY	$7.63 - $10.22 $8,980 - $12,028	1,177 Added 2.38%	50,544 $485,000
Q3 2022 Nov 14, 2022	SELL	$5.71 - $8.54 $11,431 - $17,097	-2,002 Reduced 3.9%	49,367 $399,000
Q2 2022 Aug 12, 2022	SELL	$5.17 - $6.33 $20,524 - $25,130	-3,970 Reduced 7.17%	51,369 $287,000
Q1 2022 May 12, 2022	SELL	$4.29 - $6.08 $9,266 - $13,132	-2,160 Reduced 3.76%	55,339 $310,000
Q4 2021 Feb 10, 2022	BUY	$3.89 - $10.01 $692 - $1,781	178 Added 0.31%	57,499 $253,000
Q3 2021 Nov 09, 2021	SELL	$6.51 - $9.62 $33,630 - $49,696	-5,166 Reduced 8.27%	57,321 $541,000
Q2 2021 Aug 11, 2021	BUY	$5.96 - $7.85 $372,422 - $490,522	62,487 New	62,487 $455,000

Others Institutions Holding FENC

# of Institutions

Shares Held

14.3M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $136M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account